Tenet Healthcare raises 2026 adjusted EBITDA outlook to $5.05 billion-$5.2 billion
THC•Tenet Healthcare raised its fiscal 2026 adjusted EBITDA outlook by $195 million to $5.05 billion-$5.2 billion. It also increased its adjusted free cash flow forecast by $100 million to $1.93 billion-$2.16 billion.
1. Updated 2026 outlook
Tenet Healthcare raised its fiscal 2026 adjusted EBITDA guidance by $195 million to $5.05 billion-$5.2 billion. The company forecasts revenue of $22.05 billion-$22.45 billion and adjusted diluted earnings of $22.05-$23.01 per share.
2. Quarter and transition impacts
Third-quarter adjusted EBITDA rose 23.3% to $1.36 billion, including $147 million in favorable transition impacts. Contract transition activities are expected to contribute approximately $450 million to full-year adjusted EBITDA, but those contributions are not expected to recur in 2027.
